Clinical Trials Directory

Trials / Completed

CompletedNCT04872140

Effect of Iron-fortified Pea Powder on Exercise Performance

Effect of Low-phytate Pea Powder With High Iron Bioavailability on Iron Status of Female Runners

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
University of Saskatchewan · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Female endurance athletes are susceptible to iron deficiency and this can impact their exercise performance. This study assesses the impact of an pea protein supplement with high iron bio-availability on iron status and exercise performance.

Detailed description

Female endurance athletes are susceptible to iron deficiency due to poor iron intake from diets or possibly because of destruction of red blood cells during foot-strike hemolysis. This study will evaluate the impact of 8-weeks of iron supplementation through consumption of a pea-protein power that has high iron bio-availability due to low phytate levels. This will be compared to consumption of regular iron protein powder and maltodextrin placebo by randomizing participants to three groups. Participants will be assessed at baseline and after 8 weeks of supplementation for exercise performance (maximal aerobic capacity and a 5 km time trial running test), blood levels of ferritin and hemoglobin, and body composition (fat mass and lean tissue mass).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLow phytate pea powderExercise performance with low phytate pea powder
DIETARY_SUPPLEMENTRegular pea powderExercise performance with regular pea powder
DIETARY_SUPPLEMENTPlacebo (maltodextrin)Exercise performance with placebo (maltodextrin)

Timeline

Start date
2021-05-03
Primary completion
2022-06-30
Completion
2022-08-15
First posted
2021-05-04
Last updated
2022-10-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04872140. Inclusion in this directory is not an endorsement.